Novartis funds independent educational programs to advance clinical and scientific knowledge of Sjögren's disease, focusing on early diagnosis, multidisciplinary care, and emerging therapies for US healthcare professionals.
Funder: Novartis
Due Dates: June 29, 2026 (Full application deadline, 5 PM EST)
Funding Amounts: Total funding available: $400,000; maximum per initiative: $300,000.
Summary: Supports independent, innovative medical education programs to advance knowledge and multidisciplinary care in Sjögren's disease for US healthcare professionals.
This grant opportunity from the Novartis Office of Grants & Education seeks to fund independent, high-quality medical education programs focused on Sjögren's disease. The aim is to close clinical and scientific gaps by supporting educational initiatives that address the disease’s systemic and heterogeneous nature, promote early diagnosis and appropriate patient stratification, and encourage evidence-based, multidisciplinary care. Funded programs should also cover disease burden, mechanisms of autoimmune response, emerging investigational therapies, and the integration of new science into clinical practice. Activities must be fair-balanced, evidence-based, and independent of commercial interests, with formats including symposia, workshops, toolkits, and podcasts.